217 related articles for article (PubMed ID: 17275297)
1. Synthesis and biological evaluation of unprecedented classes of spiro-beta-lactams and azido-beta-lactams as acyl-CoA:cholesterol acyltransferase inhibitors.
Benfatti F; Cardillo G; Gentilucci L; Tolomelli A
Bioorg Med Chem Lett; 2007 Apr; 17(7):1946-50. PubMed ID: 17275297
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of azido- and aziridino-hydroxyl-beta-lactams through stereo- and regioselective epoxide ring opening.
Benfatti F; Cardillo G; Gentilucci L; Perciaccante R; Tolomelli A; Catapano A
J Org Chem; 2006 Nov; 71(24):9229-32. PubMed ID: 17109554
[TBL] [Abstract][Full Text] [Related]
3. Predicting acyl-coenzyme A: cholesterol O-acyltransferase inhibitory activity: computational approach using topological descriptors.
Lather V; Madan AK
Drug Des Discov; 2003; 18(4):117-22. PubMed ID: 15553923
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activity of novel 4-phenyl-1,8-naphthyridin-2(1H)-on-3-yl ureas: potent acyl-CoA:cholesterol acyltransferase inhibitor with improved aqueous solubility.
Ban H; Muraoka M; Ioriya K; Ohashi N
Bioorg Med Chem Lett; 2006 Jan; 16(1):44-8. PubMed ID: 16242323
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of SMP-797, a novel acyl-coenzyme a: cholesterol acyltransferase inhibitor with inducible effect on the expression of low-density lipoprotein receptor.
Ioriya K; Kino K; Horisawa S; Nishimura T; Muraoka M; Noguchi T; Ohashi N
J Cardiovasc Pharmacol; 2006 Feb; 47(2):322-9. PubMed ID: 16495773
[TBL] [Abstract][Full Text] [Related]
6. Polyacetylenic compounds, ACAT inhibitors from the roots of Panax ginseng.
Rho MC; Lee HS; Lee SW; Chang JS; Kwon OE; Chung MY; Kim YK
J Agric Food Chem; 2005 Feb; 53(4):919-22. PubMed ID: 15712998
[TBL] [Abstract][Full Text] [Related]
7. Acyl-coenzyme A:cholesterol acyltransferase inhibitors for controlling hypercholesterolemia and atherosclerosis.
Miyazaki A; Sakai M; Sakamoto Y; Horiuchi S
Curr Opin Investig Drugs; 2003 Sep; 4(9):1095-9. PubMed ID: 14582454
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of enantiopure pyrrolidine-derived peptidomimetics and oligo-beta-peptides via nucleophilic ring-opening of beta-lactams.
Macías A; Ramallal AM; Alonso E; del Pozo C; González J
J Org Chem; 2006 Sep; 71(20):7721-30. PubMed ID: 16995679
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, docking and in vitro antimalarial evaluation of bifunctional hybrids derived from β-lactams and 7-chloroquinoline using click chemistry.
Singh P; Singh P; Kumar M; Gut J; Rosenthal PJ; Kumar K; Kumar V; Mahajan MP; Bisetty K
Bioorg Med Chem Lett; 2012 Jan; 22(1):57-61. PubMed ID: 22172698
[TBL] [Abstract][Full Text] [Related]
10. 3-Alkenyl-2-azetidinones as fatty acid amide hydrolase inhibitors.
Urbach A; Muccioli GG; Stern E; Lambert DM; Marchand-Brynaert J
Bioorg Med Chem Lett; 2008 Jul; 18(14):4163-7. PubMed ID: 18547805
[TBL] [Abstract][Full Text] [Related]
11. Novel 3,5-diaryl pyrazolines as human acyl-CoA:cholesterol acyltransferase inhibitors.
Jeong TS; Kim KS; An S; Cho KH; Lee S; Lee WS
Bioorg Med Chem Lett; 2004 Jun; 14(11):2715-7. PubMed ID: 15125920
[TBL] [Abstract][Full Text] [Related]
12. Selectivity of microbial acyl-CoA: cholesterol acyltransferase inhibitors toward isozymes.
Ohshiro T; Rudel LL; Omura S; Tomoda H
J Antibiot (Tokyo); 2007 Jan; 60(1):43-51. PubMed ID: 17390588
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel 4,5-diphenylthiazole derivatives as potential acyl-CoA:cholesterol O-acyltransferase inhibitors.
Romeo G; Salerno L; Milla P; Siracusa M; Cattel L; Russo F
Pharmazie; 1999 Jan; 54(1):19-23. PubMed ID: 9987793
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel acyl coenzyme a: cholesterol acyltransferase inhibitors: pharmacophore-based virtual screening, synthesis and pharmacology.
Chhabria MT; Brahmkshatriya PS; Mahajan BM; Darji UB; Shah GB
Chem Biol Drug Des; 2012 Jul; 80(1):106-13. PubMed ID: 22429570
[TBL] [Abstract][Full Text] [Related]
15. Selectivity of pyripyropene derivatives in inhibition toward acyl-CoA:cholesterol acyltransferase 2 isozyme.
Ohshiro T; Ohte S; Matsuda D; Ohtawa M; Nagamitsu T; Sunazuka T; Harigaya Y; Rudel LL; Omura S; Tomoda H
J Antibiot (Tokyo); 2008 Aug; 61(8):503-8. PubMed ID: 18997389
[TBL] [Abstract][Full Text] [Related]
16. Discovery and combinatorial synthesis of fungal metabolites beauveriolides, novel antiatherosclerotic agents.
Tomoda H; Doi T
Acc Chem Res; 2008 Jan; 41(1):32-9. PubMed ID: 17803269
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationship studies on a novel series of naphthylidinoylureas as inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT).
Ohnuma S; Muraoka M; Ioriya K; Ohashi N
Bioorg Med Chem Lett; 2004 Mar; 14(5):1309-11. PubMed ID: 14980688
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of acyl-CoA cholesterol acyltransferase by F12511 (Eflucimibe): could it be a new antiatherosclerotic therapeutic?
López-Farré AJ; Sacristán D; Zamorano-León JJ; San-Martín N; Macaya C
Cardiovasc Ther; 2008; 26(1):65-74. PubMed ID: 18466422
[TBL] [Abstract][Full Text] [Related]
19. Nucleophilic ring-opening of epoxide and aziridine acetates for the stereodivergent synthesis of β-hydroxy and β-amino γ-lactams.
Bisol TB; Bortoluzzi AJ; Sá MM
J Org Chem; 2011 Feb; 76(3):948-62. PubMed ID: 21194209
[TBL] [Abstract][Full Text] [Related]
20. Bavachin and isobavachalcone, acyl-coenzyme A: cholesterol acyltransferase inhibitors from Psoralea corylifolia.
Choi JH; Rho MC; Lee SW; Choi JN; Kim K; Song GY; Kim YK
Arch Pharm Res; 2008 Nov; 31(11):1419-23. PubMed ID: 19023538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
